BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6299534)

  • 1. Role of suppressor cells in feline leukemia virus-associated immunosuppression.
    Langweiler M; Cockerell GL; deNoronha F
    Cancer Res; 1983 May; 43(5):1957-60. PubMed ID: 6299534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
    Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
    Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the short-lived suppressive function of peripheral leukocytes in feline retrovirus-infected cats.
    Stiff MI; Olsen RG
    J Clin Lab Immunol; 1982 Feb; 7(2):133-8. PubMed ID: 6279852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines.
    Dunlap JE; Nichols WS; Hebebrand LC; Mathes LE; Olsen RG
    Cancer Res; 1979 Mar; 39(3):956-8. PubMed ID: 218726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of normal lymphocyte mitogenic reactivity by serum from feline leukemia virus-infected cats.
    Cockerell GL; Hoover EA
    Cancer Res; 1977 Nov; 37(11):3985-9. PubMed ID: 198125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus.
    Hebebrand LC; Mathes LE; Olsen RG
    Cancer Res; 1977 Dec; 37(12):4532-3. PubMed ID: 200353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of retrovirus suppression of human T cell proliferation in vitro.
    Copelan EA; Rinehart JJ; Lewis M; Mathes L; Olsen R; Sagone A
    J Immunol; 1983 Oct; 131(4):2017-20. PubMed ID: 6311904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus.
    Hebebrand LC; Olsen RG; Mathes LE; Nichols WS
    Cancer Res; 1979 Feb; 39(2 Pt 1):443-7. PubMed ID: 216488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein.
    Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP
    Nature; 1978 Aug; 274(5672):687-9. PubMed ID: 209338
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection and evaluation of feline oncornavirus-induced cell surface antigen(s) shed from cells in vitro.
    Wolff LH; Mathes LE; Schaller JP; Hoover EA; Olsen RG
    Cancer Res; 1977 Nov; 37(11):4134-7. PubMed ID: 198129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 suppression in cats naturally infected with feline leukemia virus.
    Tompkins MB; Ogilvie GK; Gast AM; Franklin R; Weigel R; Tompkins WA
    J Biol Response Mod; 1989 Feb; 8(1):86-96. PubMed ID: 2537886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement.
    Grant CK; DeBoer DJ; Essex M; Worley MB; Higgins J
    J Immunol; 1977 Aug; 119(2):401-6. PubMed ID: 196021
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
    Lizonová A; Grófová M
    Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of feline retroviral suppression by indomethacin.
    Lewis MG; Fertel RH; Olsen RG
    Leuk Res; 1985; 9(12):1451-6. PubMed ID: 3001436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens.
    Lee TH; Essex M; de Noronha F; Azocar J
    Cancer Res; 1982 Oct; 42(10):3995-9. PubMed ID: 6286102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of suppression of lymphocyte proliferation by Concanavalin A-activated mononuclear cells.
    Lomnitzer R; Rabson AR
    Immunology; 1981 Jul; 43(3):475-81. PubMed ID: 6454655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of virus-induced immune suppression.
    Strayer DS; Leibowitz JL
    J Immunol; 1986 Apr; 136(7):2649-53. PubMed ID: 3005416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and tumor antibody levels in cats, and changes associated with natural feline leukemia virus infection and malignant disease.
    Grant CK; Pickard DK; Ramaika C; Madewell BR; Essex M
    Cancer Res; 1979 Jan; 39(1):75-81. PubMed ID: 216484
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of feline leukemia virus-infected and normal cat T-cell lines in interleukin 2-conditioned medium.
    Grant CK; Ernisse BJ; Pontefract R
    Cancer Res; 1984 Feb; 44(2):498-502. PubMed ID: 6318972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.